Pages
Products

pcDNA3.1(+)

For research use only. Not intended for any clinical use.
Cat.No.
VET1450
Background
pCDNA3.1(+) is a 5.4 kb vector derived from pCDNA3 designed for high-level stable and transient expression in mammalian hosts. Most mammalian cells are capable of high levels of stable and non-replicative transient expression. Human cytomegalovirus immediate early (CMV) promoter for high-level expression in a wide range of mammalian cells. Multiple cloning sites in forward (+) and reverse (-) directions to facilitate cloning of neomycin resistance genes for selection of stable cell lines. Aberrant replication in cell lines latently infected with SV40 or expressing the SV40 large T antigen (e.g., COS-1, COS-7).
Host Cell
mammalian cells, Escherichia coli
Promoter
CMV
Resistance
Ampicillin
Selection
Neomycin
Vector Size
5428 bp
Vector Type
Expression Vector

Applications

Publications

Q & A

Customer Reviews

The pcDNA3.1(+) plasmid is a widely used expression vector in molecular biology and genetic engineering research. Its numerous applications include: 1. Cloning and expression of target genes: pcDNA3.1(+) enables the cloning of target genes of interest into the multiple cloning site (MCS) within the plasmid. The inserted gene can be expressed under the control of a strong constitutive promoter, such as the cytomegalovirus (CMV) promoter, allowing researchers to produce large amounts of the protein encoded by the gene. 2. Gene overexpression studies: By expressing a gene of interest using pcDNA3.1(+), researchers can study the effects of gene overexpression on cellular processes, pathways, or phenotypes. 3. Construction of reporter gene vectors: pcDNA3.1(+) can be used to construct reporter gene vectors for monitoring gene expression or protein function. 4. Vaccine and therapeutic protein production: The pcDNA3.1(+) vector can be used for the production of recombinant proteins, including vaccines or therapeutic proteins. It offers a system for the large-scale production of proteins, allowing for potential use in biopharmaceutical applications.
Customer Q&As
Which enzyme is recommended for linearizing pcDNA3.1 vectors to produce stable transfectants?

A: Although not required, if you want to linearize the pcDNA3.1 vector before stable transfection, Pvu I or Sca I are single-cutting enzymes that cut within the ampicillin resistance gene and should work well.

What are pcDNA3.1(+) vector derived from?

A: They are derived from pcDNA3 vector.

In which type of cells can pcDNA3.1(+) vector carry out high-level stable and non-replicative transient expression?

A: It can carry out high-level stable and non-replicative transient expression in most mammalian cells.

What is the difference between pcDNA3.1 vector and pcDNA3.3-TOPO vector?

A: The pcDNA3.1 vector contains the core CMV promoter that is truncated before the initiation of transcription, while the pcDNA 3.3-TOPO vector contains 672 bp of the native CMV promoter.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High-level expression

pcDNA3.1(+) enables high-level expression in a wide range of mammalian cells. This has greatly enhanced the overall value of our research.

Germany

01/14/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Quick Inquiry

Inquiry